- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IV Squamous Cell Carcinoma of the Head and Neck in United Kingdom
Total 2518 results
-
Joseph CalifanoJohns Hopkins University; NYU Langone Health; Greater Baltimore Medical Center; San Diego Veterans Healthcare System and other collaboratorsCompletedSquamous Cell Carcinoma of the Head and Neck | Oropharynx Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Squamous Cell Carcinoma of the OropharynxUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedHead and Neck Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States
-
Aethlon Medical Inc.TerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
National Cancer Institute (NCI)RecruitingHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Metastatic... and other conditionsUnited States
-
Celldex TherapeuticsCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
University of CincinnatiTerminatedHead and Neck CancerUnited States
-
David A. Clump, MD, PhDCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Yale UniversityBoehringer Ingelheim; National Comprehensive Cancer NetworkRecruitingSquamous Cell Cancers of the Head and NeckUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMucositis | Tongue Cancer | Oral Complications | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Verrucous Carcinoma of the Larynx | Recurrent... and other conditionsUnited States
-
University of PittsburghTerminatedSquamous Cell Carcinoma of the Head and Neck | Primary Advanced Carcinoma of the Oral Cavity or OropharynxUnited States
-
Medical University of South CarolinaRecruiting
-
University of California, San DiegoPharmacyclics LLC.Active, not recruitingHead and Neck Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States
-
Bristol-Myers SquibbCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of Kansas Medical CenterCelgene CorporationTerminatedSquamous Cell CarcinomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Caregiver | Salivary Gland Squamous Cell Carcinoma | Malignant Head and Neck Neoplasm | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Stage... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingTongue Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Verrucous Carcinoma of the Larynx | Recurrent Verrucous Carcinoma of the Oral Cavity | Recurrent Adenoid... and other conditionsUnited States
-
University of California, San DiegoRecruitingCancer | Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Head and Neck Carcinoma | Cancer of Head and Neck | Head and Neck Cancer Metastatic | Head and Neck Cancer Stage IV | Cancer of Esophagus | Cancer, Metastatic | Head and Neck Cancer Stage III | Cancer of Mouth | Cancer of NeckUnited States
-
Washington University School of MedicineCelgene CorporationCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
CelgeneTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
University of Michigan Rogel Cancer CenterNational Institutes of Health (NIH)Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of ArkansasWithdrawnSquamous Cell Carcinoma of the Head and NeckUnited States
-
Genentech, Inc.Completed
-
University of Michigan Rogel Cancer CenterCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Nina BhardwajOncovir, Inc.TerminatedMelanoma | Breast Cancer | Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the Skin | Sarcoma of the Skin | Basal Cell Cancer of the SkinUnited States
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Julie E. Bauman, MD, MPHNovartisTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of Tennessee Cancer InstituteNational Comprehensive Cancer NetworkTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Japan, Spain, Taiwan, Korea, Republic of, France, Poland, Russian Federation, Turkey
-
Vaccinex Inc.Merck Sharp & Dohme LLCRecruitingRecurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)United States
-
University of ArkansasActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of ArkansasWithdrawnSquamous Cell Carcinoma of the Head and NeckUnited States
-
Dan ZandbergBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of ChicagoAstraZenecaCompletedHead and Neck NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedRadiation Toxicity | Malignant Neoplasm | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Mixed Glioma | Adult Oligodendroglioma | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the... and other conditionsUnited States
-
Bristol-Myers SquibbCompletedHead and Neck CancerUnited States, Brazil, Italy, South Africa, Spain, Canada, Argentina, Belgium, Chile, Czechia, Finland, France, Ireland, Mexico, Netherlands, Norway, Romania, Russian Federation, Sweden, Turkey, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Head and Neck Squamous Cell Carcinoma | Second Primary Squamous Cell Carcinoma of the Head and NeckUnited States
-
Rain Oncology IncTerminatedMetastatic Head-and-neck Squamous-cell CarcinomaUnited States, Australia
-
Ezra CohenMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckBrazil, Italy, United Kingdom, United States, Hong Kong, France, Netherlands, Germany, Argentina, Canada, Japan, Korea, Republic of, Spain, Switzerland, Taiwan
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
Dana-Farber Cancer InstituteWithdrawnSquamous Cell Carcinoma of the OropharynxUnited States
-
Hoffmann-La RocheCompletedHead and Neck CancerSpain, France, United Kingdom, Netherlands, Italy
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyWithdrawnTongue Cancer | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Verrucous Carcinoma of the Oral Cavity | Stage IVA Verrucous Carcinoma of the Oral Cavity | Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage IVB Verrucous Carcinoma of the Oral Cavity | Stage IVA Squamous Cell Carcinoma of the Lip and Oral CavityUnited States
-
Dana-Farber Cancer InstituteTerminatedSquamous Cell Carcinoma of the Head and Neck | Human Papilloma VirusUnited States